DOUGLAS S. INGRAM - 07 Dec 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Chief Executive Officer, Director
Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Douglas S. Ingram
Issuer symbol
SRPT
Transactions as of
07 Dec 2025
Net transactions value
$0
Form type
4
Filing time
09 Dec 2025, 20:30:03 UTC
Previous filing
06 Jun 2025
Next filing
18 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
INGRAM DOUGLAS S Chief Executive Officer, Director 215 FIRST STREET, SUITE 415, CAMBRIDGE /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Douglas S. Ingram 09 Dec 2025 0001190644

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Award $0 +50,000 +13% $0.000000 440,307 07 Dec 2025 Direct F1
transaction SRPT Common Stock Award $0 +50,000 +11% $0.000000 490,307 07 Dec 2025 Direct F2
transaction SRPT Common Stock Award $0 +73,001 +15% $0.000000 563,308 07 Dec 2025 Direct F3
transaction SRPT Common Stock Award $0 +96,541 +17% $0.000000 659,849 07 Dec 2025 Direct F4
transaction SRPT Common Stock Award $0 +269,542 +41% $0.000000 929,391 07 Dec 2025 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted performance-contingent restricted stock units ("Performance-Contingent RSUs"), as described in the Company's 2018 Equity Incentive Plan. Each Performance-Contingent RSU represents the right to receive one share of common stock. The Performance-Contingent RSUs are subject to service- and performance-based vesting criteria.
F2 The Reporting Person was granted restricted shares, as described in the Company's 2018 Equity Incentive Plan. The restricted shares are subject to service- and performance-based vesting criteria.
F3 The Reporting Person was granted Performance Units, as described in the Company's 2018 Equity Incentive Plan. The Performance Units are subject to service- and performance-based vesting criteria.
F4 The Reporting Person was granted Performance Shares, as described in the Company's 2018 Equity Incentive Plan. The Performance Shares are subject to service- and performance-based vesting criteria.
F5 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs are subject to service- and performance-based vesting criteria.